Based on these data, it is proposed that RG6016 may modulate the HIF-1α pathway via LSD1, UCHL1, and MYC in aggressive cancers such as SCLC, thereby influencing key processes like hypoxia response, metastasis, and neuroendocrine differentiation. This evidence concerns the gene HIF1A and small cell lung carcinoma.